Pallidin Homolog (PLDN) Peptide
PLDN
Reactivity: Human
Host: Synthetic
BP, BI
-
- Target See all Pallidin (PLDN) products
- Pallidin (PLDN) (Pallidin Homolog (PLDN))
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), BioImaging (BI)
- Characteristics
- Pallidin peptide corresponds to 14 amino acids of Pallidin.
-
-
- Application Notes
- Pallidin Peptide is used for blocking the activity of Pallidin antibody . The Pallidin antibody ships at 0.5 mg/mL and the Pallidin Peptide ships as a 100 μg pellet. When peptide is reconstituted in 200 μLwater, the concentration will be 0.5 mg/mL, identical to that of the antibody. The best starting ratio would be 1:1 (which means molar excess of peptide relative to antibody when identical volumes are mixed). Mix equal volume of peptide and antibody at the required dilution and leave at ambient temperature for 20 minutes. Then incubate and develop in parallel two blots: one with the antibody and one with the antibody which has been pre-absorbed with the provided peptide.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Pallidin peptide is supplied as 100 µg of dried peptide. When the peptide is reconstituted in 200 µL water, the concentration will be 0.5 mg/mL.
- Storage
- -20 °C
- Storage Comment
- Store at -20°C. When reconstituted minimize freezing and thawing.
-
- Target
- Pallidin (PLDN) (Pallidin Homolog (PLDN))
- Synonyms
- CG14133 Peptide, Dmel\\CG14133 Peptide, LOC100226487 Peptide, pldn Peptide, BLOS6 Peptide, HPS9 Peptide, PA Peptide, PALLID Peptide, PLDN Peptide, Pldn Peptide, BLOC-1 Peptide, Stx13bp1 Peptide, pa Peptide, pallidin Peptide, CG14133 gene product from transcript CG14133-RB Peptide, biogenesis of lysosomal organelles complex 1 subunit 6 Peptide, pallidin homolog (mouse) Peptide, biogenesis of lysosomal organelles complex-1, subunit 6, pallidin Peptide, Pallidin Peptide, BLOC1S6 Peptide, pldn Peptide, Bloc1s6 Peptide
- Gene ID
- 26258
- NCBI Accession
- NP_036520
- OMIM
- 6912574
- UniProt
- Q9UL45
-
You are here:
